Lite Strategy logo
Lite Strategy
LITS | NASDAQ
Chart Builder DCF Calculator
$0.86
+$0.01 (+1.57%)
At close: Nov 16, 2026, 4:00 PM ET
$0.86
$0.00 (-0.41%)
After-hours: Nov 16, 2026, 4:15 PM ET

Lite Strategy Company Profile

Company profile explained

Company Profile

Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.

Key Executives

Name Position
Justin J. File CEO, CFO, Corporate Secretary & Director
Anne Frese Chief People Officer
Robert D. Mass Strategic Advisor

Latest SEC Filings

Date Type Title
Oct 26, 2026 4 Filing
Oct 26, 2026 4 Filing
Oct 26, 2026 4 Filing
Oct 26, 2026 4 Filing
Oct 26, 2026 4 Filing
May 13, 2026 8-K Current Report
May 13, 2026 10-Q Quarterly Report
Feb 17, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Feb 17, 2026 8-K Current Report
Feb 17, 2026 10-Q Quarterly Report
View All SEC Filings ➞
Lite Strategy
Lite Strategy logo
Country United States
IPO Date Dec 18, 2003
Industry Biotechnology
Sector Healthcare
Employees 5
CEO Justin J. File

Contact Details

9920 Pacific Heights Blvd. San Diego, California 92121 United States

Stock Details

Ticker Symbol LITS
Exchange NASDAQ
Fiscal Year July - June
Reporting Currency USD
CIK Code 0001262104
CUSIP Number 55279B301
ISIN Number US55279B3015
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.